Alcohol abuse anxiety with

In addition, if possible, die nurse obtains a history of any past drug or alcohol abuse. Individuals with a history of previous abuse are more likely to abuse odier drug s, such as the antianxiety drug s. Some patients, such as diose with mild anxiety or depression, do not necessarily require inpatient care. These patients are usually seen at periodic intervals in die primary health care provider s office or in a psychiatric outpatient setting. The preadministration assessments of the outpatient are the same as diose for the hospitalized patient. 

Cessation of prolonged heavy alcohol abuse may be followed by alcohol withdrawal or life-threatening alcohol withdrawal delirium. Typical withdrawal symptoms are autonomic hyperactivity, increased hand tremor, insomnia and anxiety, and are treated with benzodizepines and thiamine. Alcoholism is the most common cause of thiamine deficiency and can lead in its extreme form to the Wernicke s syndrome that can be effectively treated by high doses of thiamine. 

Ciraulo DA, Jaffe JH Tricyclic antidepressants in the treatment of depression associated with alcoholism. Clin Psychopharmacol 1 146—150, 1981 Ciraulo DA, Nace E Benzodiazepine treatment of anxiety or insomnia in substance abuse patients. Am J Addict 9 276—284, 2000 Ciraulo DA, Barnhill JG, Jaffe JH, et al Intravenous pharmacokinetics of 2-hydroxy-imipramine in alcoholics and normal controls. J StudAlcohol 51 366-372, 1990 Ciraulo DA, Knapp CM, LoCastro J, et al A benzodiazepine mood effect scale reliability and validity determined for alcohol-dependent subjects and adults with a parental history of alcoholism. Am J Drug Alcohol Abuse 27 339—347, 2001 Collins MA Tetrahydropapaveroline in Parkinson s disease and alcoholism a look back in honor of Merton Sandler. Neurotoxicology 25 117-120, 2004 COMBINE Study Research Group Testing combined pharmacotherapies and behavioral interventions in alcohol dependence rationale and methods. Alcohol Clin Exp Res 27 1107-1122, 2003a... 

Benzodiazepines have a low risk for abuse in anxiety disorder patients without a history of alcohol or other substance abuse. Among the benzodiazepines there may be a spectrum of abuse liability, with drugs that serve as prodrugs for desmethyldiazepam (e.g., clorazepate), slow-onset agents (e.g., oxazepam), and partial agonists (e.g., abecarnil) having the least potential for abuse. However, there is no currently marketed benzodiazepine or related drug that is free of potential for abuse. 

High-potency benzodiazepines (e.g., clonazepam and lorazepam) are common alternatives to or in combination with antipsychotics for acute mania, agitation, anxiety, panic, and insomnia or in those who cannot take mood stabilizers. Lorazepam IM may be used for acute agitation. A relative contraindication for long-term benzodiazepines is a history of drug or alcohol abuse or dependency. 

Most bulimic patients (60%-80%) have a lifetime history of depression (Braun et ah, 1994). They have problems with interpersonal relationships, self-concept, and impulsive behavior and show high levels of anxiety and compulsivity. Chemical dependency is not unusual in this disorder, alcohol abuse being the most common. Bulimics will abuse amphetamines to reduce their appetite and lose weight (Braun et ah, 1994). 

Although depression is the most prominent comorbid illness, a variety of other psychiatric conditions may be associated with panic disorder, for example, agoraphobia [60% of patients with panic disorder], other anxiety disorders (20%), and drug and alcohol abuse [15%] [Klerman 1992). 

The major benefit of BZDs may be in diminishing some of the secondary symptoms of an acute exacerbation (e.g., insomnia, agitation, panic, and other general anxiety symptoms) that are not necessarily rapidly and specifically affected by lithium or antipsychotics. With this approach, exposure to antipsychotics may be precluded in some situations and kept to a minimum in others, thus avoiding the potential for more serious antipsychotic-induced adverse effects. Additionally, given the high comorbidity with alcohol abuse/dependence, concurrent withdrawal symptoms may also be managed with BZDs. 

Abrupt alcohol withdrawal leads to a characteristic syndrome of motor agitation, anxiety, insomnia, and reduction of seizure threshold. The severity of the syndrome is usually proportionate to the degree and duration of alcohol abuse. However, this can be greatly modified by the use of other sedatives as well as by associated factors (eg, diabetes, injury). In its mildest form, the alcohol withdrawal syndrome of tremor, anxiety, and insomnia occurs 6-8 hours after alcohol consumption is stopped (Figure 23-2). These effects usually abate in 1-2 days. In some patients, more severe withdrawal reactions occur, with patients at risk of hallucinations or generalized seizures during the first 1-3 days of withdrawal. Alcohol withdrawal is one of the most common causes of seizures in adults. Several days later, individuals can develop the syndrome of delirium tremens, which is characterized by total disorientation, hallucinations, and marked abnormalities of vital signs. 

Posttraumatic stress disorder (PTSD) is another anxiety disorder that can be characterized by attacks of anxiety or panic, but it is notably different from panic disorder or social phobia in that the initial anxiety or panic attack is in response to a real threat (being raped, for example) and subsequent attacks are usually linked to memories, thoughts, or flashbacks of the original trauma. The lifetime incidence of PTSD is about 1%. Patients have disturbed sleep and frequent sleep complaints. Comorbidities with other psychiatric disorders, especially depression and drug and alcohol abuse, are the rule rather than the exception. The DSM-IV diagnostic criteria are given in Table 9—11. 

Understand the major psychiatric disorders treated with psychotropic agents, including depression, anxiety disorders, psychosis, cognitive disorders including dementia and drug and alcohol abuse. 

The therapist continues to work collaboratively with Dr. D to address Ms. A s many health concerns her skin disorder, her symptoms of anxiety and depression, her weight gain, and her continued alcohol abuse. Physician, therapist, and patient make explicit that connection among the various problems she experiences her inability to identify the source of her stress and her reluctance to express that stress seem to cause her skin disorder to flare up. She seeks alcohol in order to soothe herself, and as the months pass with no improvements in her physical or emotional health, she continues to turn to drink as the only way to combat the anger and frustration she feels about many aspects of her life. 

An additional psychotropic medication that may be worth considering specifically for GAD is buspirone. One major benefit of buspirone can be found in the virtual absence of dependence and abuse liability. Although it is not effective for the acute relief of anxiety or panic disorders (anxiolytic effects may take up to a week to be established), buspirone may be indicated for patients with a history of alcohol abuse or among those who fear physiologic and psychological dependence with benzodiazepines. 

Panic disorder is characterized by recurring, intense panic attacks. Many times these attacks appear to be spontaneous, not provoked by identifiable stressors. As the disorder progresses, most patients begin to develop considerable anticipatory anxiety (a rather continuous, mild-to-moderate generalized anxiety as they come to worry when the next attack will occur)—and phobias (agoraphobia is especially common). With time, alcohol abuse and depression commonly develop. 

About one quarter of the U.S. population experience some form of mental disorder in any given year. Most have symptoms associated with anxiety, depression, or alcohol abuse. 

Anxiety and dissociative symptoms (e.g., sense of numbing or absence of emotional responsiveness, derealization, depersonalization, inability to recall important features of the event) emerging within 1 month after exposure to a traumatic stressor are classified as ASD. Symptoms of ASD are experienced during or immediately after the trauma, last for at least 2 days, and resolve within 4 weeks. The age of onset and course of PTSD are variable. PTSD can occur at any age. The presentation is not predictable because symptoms are related to the duration and intensity of the trauma, the presence of other psychiatric disorders, and how the patient deals with the trauma. The average duration of symptoms in patients in treatment is about 36 months. In those not receiving treatment, symptoms can last for a mean of 5 years. About one-third of patients with PTSD have a poor prognosis for recovery. About 80% of patients with PTSD have a concurrent depression or anxiety disorder. Over half of men with PTSD suffer from comorbid alcohol abuse or dependence. About 20% of patients with PTSD attempt suicide. ... 

Patients with OCD often have comorbid depression, anxiety disorders, and alcohol abuse or dependence. It is a chronic illness in most patients, with severity of symptoms varying in intensity over time. Many patients with OCD have significantly impaired QOL and ability to function. ... 

I As with depression, anxiety may be a cause and a consequence of alcohol abuse. 

A word about prevalence mental illness is more common than many people imagine. The current prevalence estimates are that about half the U.S. population meets the criteria for at least one mental disorder during a lifetime, with about 25 percent of the population meeting the criteria for at least one mental disorder during any given year.1 Of these disorders, the most prevalent are apparently anxiety disorders, followed by mood disorders (for example, major depressive disorder), impulse-control disorders (for example, attention deficit hyperactivity disorder [ADHD]), and substance disorders (for example, alcohol abuse). In contrast, the prevalence of psychosis as I define it here is only 2—3 percent of the U.S. population, and the world prevalence is about the same. 

Benzodiazepines are used commonly in SAD however, there are limited data supporting their use. Clonazepam has been effective for social anxiety, fear, and phobic avoidance, and it reduced social and work disability during acute treatment.58 Long-term treatment is not desirable for many SAD patients owing to the risk of withdrawal and difficulty with discontinuation, cognitive side effects, and lack of effect on depressive symptoms. Benzodiazepines may be useful for acute relief of physiologic symptoms of anxiety when used concomitantly with antidepressants or psychotherapy. Benzodiazepines are contraindicated in SAD patients with alcohol or substance abuse or history of such. 

---